Absci files Form 3 for CMO, Head of R&D Somaratne Ransi Mudalinayake
ABSI•Absci files initial beneficial ownership statement
Absci filed an initial beneficial ownership statement for Somaratne Ransi Mudalinayake, chief medical officer and head of R&D.
